Stock AMGN AMGEN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Amgen Inc. Buenos Aires S.E.

Equities

AMGN

ARDEUT110665

End-of-day quote Buenos Aires S.E.
Other stock markets
 23:00:00 18/06/2024 BST 		5-day change 1st Jan Change
13,379 ARS +3.17% Intraday chart for Amgen Inc. +2.46% +43.35%
06-14 Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto DJ
06-14 Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer MT

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Amgen : Continues to Propel BiTE® Technology Innovation
PU
FDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE
PR
AMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
PR
Amgen : Leaders Hail Southern California’s Emergence as Biotech Innovation Hub
PU
Updates On Aflibercept Biosimilar Approvals And BPCIA Litigation
AQ
FDA Approves Amgen's BKEMV, The First Eculizumab Biosimilar
AQ
Amgen Files BPCIA Complaint Against Celltrion Regarding Denosumab
AQ
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE
AQ
AMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
PR
AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)
PR
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
PR
Amgen : 2024 Annual Meeting of Stockholders Presentation
PU
Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions Of Undisclosed Antibodies
AQ
Amgen : An Underrecognized Risk Factor for Heart Disease
PU
Improving treatment responses to solid tumours with trispecific TCEs
AQ
Amgen : From the Office to the Lab, Amgen Uses AI Tools to Unlock Innovation
PU
Amgen : Actress and Producer Gina Torres Urges Hispanic Americans to Prioritize Cholesterol Care
PU
Amgen : At Milken Global Conference, Bradway Calls for Protecting U.S. Policy Ecosystem That Fosters Innovation
PU
Driving Long-Term Growth: IMDELLTRA™ Approval and Information Update Presentation
PU
Astrazeneca - New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMGN Stock
  4. AMGN Stock
  5. News Amgen Inc.
  6. Press Releases